AtriCure Inventory 2010-2025 | ATRC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AtriCure inventory from 2010 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AtriCure inventory from 2010 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$218.9B
Boston Scientific (BSX)	$159.4B
Stryker (SYK)	$153B
EssilorLuxottica (ESLOY)	$136.1B
Medtronic (MDT)	$118B
Lonza Group Ag (LZAGY)	$50.9B
Haleon (HLN)	$43.8B
ResMed (RMD)	$40.1B
GE HealthCare Technologies (GEHC)	$35.4B
Agilent Technologies (A)	$33.9B
Terumo (TRUMY)	$25.3B
Koninklijke Philips (PHG)	$24.9B
Insulet (PODD)	$20.2B
Zimmer Biomet Holdings (ZBH)	$19.3B
Baxter (BAX)	$14.7B
Smith & Nephew SNATS (SNN)	$13.9B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$7B
Lantheus Holdings (LNTH)	$5.1B
Perrigo (PRGO)	$3.9B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
ICU Medical (ICUI)	$3.2B
LeMaitre Vascular (LMAT)	$1.9B
QuidelOrtho (QDEL)	$1.8B
Acuren (TIC)	$1.4B
AdaptHealth (AHCO)	$1.3B